Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and predictive biomarkers in lung cancer. A review.

Virchows Archiv : an international journal of pathology - 1 Mar 2014

Thunnissen Erik, van der Oord Kimberly, den Bakker Michael

Abstract excerpt

In lung cancer, clinically relevant prognostic information is provided by staging. Staging forms the basis for the treatment options and this is briefly summarized in the introduction. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase are biomarkers used for prediction of chemotherapy and prediction of targeted treatment. Other driver biomarkers in lung cancer (point mutations and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to ErbB Receptors
Share to FGFR1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MET gene

Share to ROS1 gene

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 24420742
DOI: 10.1007/s00428-014-1535-4

Genes

EGFR
BRAF
DDR2
FGFR1
KRAS
MET
PTEN
ROS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and predictive biomarkers in lung cancer. A review.PMID 24420742Read ↗

Prognostic and predictive biomarkers in non-small cell lung carcinoma.Semantic proximity Read ↗

Biomarkers in lung adenocarcinoma: a decade of progress.Semantic proximity Read ↗

Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.Semantic proximity Read ↗

Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time?Semantic proximity Read ↗

Prognostic markers in lung cancer: is it ready for prime time?Semantic proximity Read ↗

Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.Semantic proximity Read ↗

Biomarkers in bronchopulmonary cancer.Semantic proximity Read ↗

Clinical testing for molecular targets for personalized treatment in lung cancer.Semantic proximity Read ↗

Non-Small Cell Lung Cancer in the Era of Personalized Medicine: Molecular Tests that Matter.Semantic proximity Read ↗

Emerging Biomarkers in Personalized Therapy of Lung Cancer.Semantic proximity Read ↗

Predictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancer.Semantic proximity Read ↗

Genomic classification of lung cancer: toward a personalized treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.